Carcinoma Clinical Trials

Active, not recruiting

IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer

NCT03655002

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

City of Hope Medical Center Duarte, California, United States

Texas Oncology at Baylor Charles A Sammons Cancer Center Dallas, Texas, United States

View Trial Details

Active, not recruiting

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

NCT04147494

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Carcinoma, +58 more
Locations: Ethan Lam Los Angeles, California, United States

View Trial Details

Active, not recruiting

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

NCT01893307

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Florida Health Science Center - Gainesville Gainesville, Florida, United States

Miami Cancer Institute Miami, Florida, United States

View all 22 locations

View Trial Details

Active, not recruiting

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

NCT04068194

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +24 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

View all 46 locations

View Trial Details

Active, not recruiting

Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study

NCT04754412

Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, +30 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents

NCT06453590

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +20 more
Locations: Danderyds hospital Danderyd, Sweden

Sahlgrenska University hospital Gothenburg, Sweden

Central Hospital Karlstad Karlstad, Sweden

University Hospital Lund Lund, Sweden

View Trial Details

Active, not recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +33 more
Locations: Ellison Institute Los Angeles, California, United States

Yale-New Haven Hospital-Yale Cancer Center New Haven, Connecticut, United States

Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States

Brigham & Women's Hospital Boston, Massachusetts, United States

View all 39 locations

View Trial Details

Active, not recruiting

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study

NCT05899049

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 6000) Beijing, Beijing Municipality, China

Chongqing University Cancer Hospital ( Site 6009) Chongqing, Chongqing Municipality, China

SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 6003) Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangzhou Medical University-Urology ( Site 6036) Guangzhou, Guangdong, China

View all 17 locations

View Trial Details

Active, not recruiting

A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)

NCT05468697

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Georgetown University Medical Center ( Site 1002) Washington D.C., District of Columbia, United States

University of Chicago Medical Center ( Site 1007) Chicago, Illinois, United States

Beth Israel Deaconess Medical Center-Cancer Clinical Trials Office ( Site 1001) Boston, Massachusetts, United States

Huntsman Cancer Institute-HCI Clinical Trials Office ( Site 1004) Salt Lake City, Utah, United States

View all 13 locations

View Trial Details

Active, not recruiting

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer

NCT05394259

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +19 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions